Cargando…
Rebound increase in microRNA levels at the end of 5-FU-based therapy in colorectal cancer patients
Treatment with 5-fluorouracil (5-FU) based therapy is still used for colorectal cancer (CRC). Epigenetics has become a focus of study in cancer because of its reversibility besides its known regulatory functions. In this study, we will monitor the change in microRNAs (miRNAs) levels with 5-FU-based...
Autores principales: | Badr, Doaa, Fouad, Mariam A., Hussein, Marwa, Salem, Salem, Zekri, Abdelrahman, Shouman, Samia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469181/ https://www.ncbi.nlm.nih.gov/pubmed/37648713 http://dx.doi.org/10.1038/s41598-023-41030-7 |
Ejemplares similares
-
The Clinical Significance of Promoter Methylation of Fluoropyrimidine Metabolizing and Cyclooxygenase Genes in Colorectal Cancer
por: Fouad, Mariam Ahmed, et al.
Publicado: (2021) -
Fluoropyrimdine therapy induced alterations in interleukins expression in colorectal cancer patients
por: Fouad, Mariam A, et al.
Publicado: (2021) -
Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients
por: Fouad, Mariam A., et al.
Publicado: (2018) -
The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients
por: Abdellateif, Mona S, et al.
Publicado: (2020) -
Vesicular MicroRNA as Potential Biomarkers of Viral Rebound
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2022)